Omeros (OMER) Notes Payables (2010 - 2012)

Omeros (OMER) posted Notes Payables of $6.4 million for Q3 2012, up 2.62% sequentially from $6.2 million in Q2 2012, and up 20.82% YoY from $5.3 million in Q4 2011.

Omeros (OMER) Notes Payables (2010 - 2012) Analysis & Trends

Omeros has reported Notes Payables for 3 years, with the latest figure at $6.4 million in Q3 2012.

  • Quarterly Notes Payables rose 20.82% year-over-year to $6.4 million in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $6.4 million (up 20.82% YoY) and the FY2011 annual result came in at $5.9 million, up 1392.41% from the prior year.
  • Notes Payables improved to $6.4 million in Q3 2012 per OMER's latest filing, from $6.2 million in the prior quarter.
  • Over five years, Notes Payables peaked at $6.4 million in Q3 2012 and troughed at $395000.0 in Q4 2010.
  • A 3-year average of $4.8 million and a median of $5.9 million in 2011 frame the typical range for Notes Payables.
  • The sharpest annual moves came in 2011 and 2012: Notes Payables surged 1392.41% in 2011, then grew 20.82% in 2012.
  • Over 3 years, Notes Payables stood at $395000.0 in 2010, then soared by 1392.41% to $5.9 million in 2011, then increased by 8.11% to $6.4 million in 2012.
  • According to Business Quant data, Notes Payables over the past three periods registered $6.4 million, $6.2 million, and $6.0 million for Q3 2012, Q2 2012, and Q1 2012 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn

Historic Data

Download Data
DateValue
Sep 30, 2012 6.37 Mn
Jun 30, 2012 6.21 Mn
Mar 31, 2012 6.05 Mn
Dec 31, 2011 5.90 Mn
Sep 30, 2011 5.28 Mn
Jun 30, 2011 3.72 Mn
Dec 31, 2010 395,000.00